DK1866437T3 - Fremgangsmåde til at screene for tilstedeværelsen af en genetisk defekt associeret med dyb venøs thrombose - Google Patents

Fremgangsmåde til at screene for tilstedeværelsen af en genetisk defekt associeret med dyb venøs thrombose

Info

Publication number
DK1866437T3
DK1866437T3 DK06724134.9T DK06724134T DK1866437T3 DK 1866437 T3 DK1866437 T3 DK 1866437T3 DK 06724134 T DK06724134 T DK 06724134T DK 1866437 T3 DK1866437 T3 DK 1866437T3
Authority
DK
Denmark
Prior art keywords
screening
venous thrombosis
deep venous
genetic defect
defect associated
Prior art date
Application number
DK06724134.9T
Other languages
English (en)
Inventor
Rogier Maria Bertina
Willige Shirley Uitte De
Visser-Van Soest Maria Catharina Henrica De
Hans Luuk Vos
Frits R Rosendaal
Original Assignee
Leiden University Medical Ct L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiden University Medical Ct L filed Critical Leiden University Medical Ct L
Application granted granted Critical
Publication of DK1866437T3 publication Critical patent/DK1866437T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK06724134.9T 2005-04-01 2006-03-31 Fremgangsmåde til at screene for tilstedeværelsen af en genetisk defekt associeret med dyb venøs thrombose DK1866437T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05075764A EP1707640A1 (en) 2005-04-01 2005-04-01 Method of screening for the presence of a genetic defect associated with deep venous thrombosis
PCT/EP2006/003195 WO2006103113A2 (en) 2005-04-01 2006-03-31 Method of screnning for the presence of a genetic defect associated with deep venous thrombosis

Publications (1)

Publication Number Publication Date
DK1866437T3 true DK1866437T3 (da) 2010-09-06

Family

ID=35033652

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06724134.9T DK1866437T3 (da) 2005-04-01 2006-03-31 Fremgangsmåde til at screene for tilstedeværelsen af en genetisk defekt associeret med dyb venøs thrombose

Country Status (9)

Country Link
US (1) US8067209B2 (da)
EP (2) EP1707640A1 (da)
JP (1) JP5070197B2 (da)
CN (1) CN101155930B (da)
AT (1) ATE469987T1 (da)
DE (1) DE602006014665D1 (da)
DK (1) DK1866437T3 (da)
ES (1) ES2343269T3 (da)
WO (1) WO2006103113A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015013036A (es) * 2013-03-15 2016-05-18 Univ Iowa Res Found Composiciones promotoras.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005206543A1 (en) * 2004-01-15 2005-08-04 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method evolved for recognition of thrombophilia (mert)

Also Published As

Publication number Publication date
WO2006103113A3 (en) 2007-01-25
EP1866437B1 (en) 2010-06-02
US8067209B2 (en) 2011-11-29
CN101155930A (zh) 2008-04-02
DE602006014665D1 (de) 2010-07-15
CN101155930B (zh) 2013-08-07
ES2343269T3 (es) 2010-07-27
ATE469987T1 (de) 2010-06-15
WO2006103113A2 (en) 2006-10-05
JP5070197B2 (ja) 2012-11-07
EP1866437A2 (en) 2007-12-19
US20090269738A1 (en) 2009-10-29
JP2008533999A (ja) 2008-08-28
EP1707640A1 (en) 2006-10-04

Similar Documents

Publication Publication Date Title
WO2007062160A3 (en) Methods and compositions for sequencing a nucleic acid
NZ595305A (en) Methods and reagents for treatment and diagnosis of age-related macular degeneration
DE60231035D1 (de) Stammzellen und verfahren zu deren trennung
ATE482965T1 (de) 6-modifizierte bicyclische nukleinsäureanaloga
DE60025529D1 (de) Magnetische glasteilchen, herstellungsverfahren und benutzung
SG142154A1 (en) Methods for genomic analysis
DE602005013775D1 (de) Verbesserte methode zur transformation von sojabohnen
DE112005001317A5 (de) Polymorphismen im NOD2/Card15 Gen
WO2005071114A8 (en) Method evolved for recognition of thrombophilia (mert)
TW200602487A (en) Polypeptides having DNA polymerase activity
ATE533837T1 (de) Microginin-produzierende proteine und nukleinsäuren, einen microginin gen-cluster kodierend, sowie methoden zur herstellung von microgininen
EA201070229A1 (ru) Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
DE502004010621D1 (de) Verfahren zur Herstellung von Carbon-Keramik-Bremsscheiben
DE602006009901D1 (de) Verfahren zur herstellung von 7-ethyl-10-hydroxycamptothecin
DE602004025267D1 (de) Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
WO2007076143A3 (en) Species-specific primer sets and identification of species-specific dna sequences using genome fragment enrichment
WO2006021453A3 (en) Optimized nucleotide sequences encoding sgp 130
DE602004001627D1 (de) Methode zur Racemisierung von (S)-(+)- und (R)-(-)-10,11-Dihydro-10-hydroxy-5H-dibenzib,föazepine-5-carboxamiden und optisch angereicherten Mischungen davon
WO2005070042A8 (en) Novel chemical compounds
DE60332781D1 (de) Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C
DK1866437T3 (da) Fremgangsmåde til at screene for tilstedeværelsen af en genetisk defekt associeret med dyb venøs thrombose
DE602004022972D1 (de) Mit cmv-resistenz assoziierter molekularer marker und verwendung davon
ATE504648T1 (de) Rna-interferenz für das gen znfn3a1 als verfahren zur hemmung des wachstums von krebszellen
ATE463476T1 (de) Verfahren zur herstellung von acrysäure und polymerisierbare verbindungen